Structural analysis and expression profile of a novel gene on chromosome 5q23 encoding a Golgi-associated protein with six splice variants, and involved within the 5q deletion of a Ph(-) CML patient

Leukemia Research

Volumn 29, Issue 1, 2005, Pages 17-31

  Kamakari, Smaragda ^a   Roussou, Anastasia ^a   Jefferson, Andrew ^b   Ragoussis, Ioannis ^b   Anagnou, Nicholas P ^a,c  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

cDNA; complementary deoxuribonucleic acid; GM CSF; granulocyte macrophage colony stimulating factor; IL3; interferon regulatory factor 1; interleukin 3; IRF1; MDS; myelodysplastic syndromes; T cell transcription factor 1; TCF 1; YAC; yeast artificial chromosome

Indexed keywords

CELL PROTEIN; DISHEVELLED PROTEIN; GOLGI ASSOCIATED PROTEIN; ISOPROTEIN; PHOSPHOLIPASE D; PROLINE; UNCLASSIFIED DRUG; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CAENORHABDITIS ELEGANS; CHROMOSOME 5Q; CHROMOSOME DELETION 5; CHRONIC MYELOID LEUKEMIA; DNA FLANKING REGION; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE STRUCTURE; GENETIC CODE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; REGULATOR GENE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; GENE EXPRESSION; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA;

EID: 8444234657     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.04.019     Document Type: Article

References (53)

1. Steensma D.P., Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk. Res. 27:2003;95-120
2. Hirai H. Molecular mechanisms of myelodysplastic syndrome. Jpn. J. Clin. Oncol. 33:2003;153-160
3. Boultwood C., Fidler A.J., Strickson F., et al. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood. 99:2002;4638-4641
4. Le Beau M.M., Espinosa R., Neuman W.L., et al. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5484-5488
5. Pedersen-Bjergaard J., Pedersen M., Roulston D., et al. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood. 86:1995;3542-3552
6. Pedersen-Bjergaard J., Timshel S., Andersen M.K., et al. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases. Genes Chromosomes Cancer. 23:1998;337-349
7. Mecucci C., Rege-Cambrin G., Michaux J.L., et al. Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease. Br. J. Haematol. 64:1986;699-706
8. Willman C.L., Sever C.E., Pallavicini M.G., et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science. 259:1993;968-971
9. Boultwood J., Fidler C., Lewis S., Kelly S., Sheridan H., Littlewood T.J., et al. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics. 19:1994;425-432
10. Fairman J., Chumakov I., Chinault A.C., et al. Physical mapping of the minimal region of loss in 5q- chromosome. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7406-7410
11. Horrigan S.K., Arbieva Z.H., Xie H.Y., et al. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood. 95:2000;2372-2377
12. Li Y.S., Luke B., Wang H.S., et al. Deletion of one GM-CSF allele and rearrangement of the other in a patient with myelodysplastic syndrome: possible loss of functions of a tumour suppressor gene closely linked to the GM-CSF locus on chromosome 5. Br. J. Haematol. 79:1991;126-127
13. Harada H., Kitagawa M., Tanaka N., et al. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 259:1993;971-974
14. Szpirer C., Szpirer J., Riviere M., et al. Chromosomal assignment of three rat and human H-rev genes, putative tumor suppressors, down-regulated in malignantly HRAS-transformed cells. Mamm. Genome. 7:1996;701-703
15. Yang Y.C., Kovacic S., Kriz R., et al. The human genes for GM-CSF and IL 3 are closely linked in tandem on chromosome 5. Blood. 71:1988;958-961
16. Boultwood J., Rack K., Kelly S., Madden J., Sakaguchi A.Y., Wang L.M., et al. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6176-6180
17. Zhao N., Lai F., Fernald A.A., Eisenbart J.D., et al. Human CDC23: cDNA cloning, mapping to 5q31, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias. Genomics. 53:1998;184-190
18. Godley L.A., Lai F., Liu J., et al. TTID: A novel gene at 5q31 encoding a protein with titin-like features. Genomics. 60:1999;226-233
19. Lai F., Godley L.A., Fernald A.A., Orelli B.J., et al. cDNA cloning and genomic structure of three genes localized to human chromosome band 5q31 encoding potential nuclear proteins. Genomics. 70:2000;123-130
20. Green W.B., Slovak M.L., Chen I.M., et al. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del (5)(q31). Leukemia. 13:1999;1960-1971
21. Midmer M., Haq R., Squire J.A., et al. Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase-/cyclin-dependent kinase-related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion. Cancer Res. 59:1999;4069-4074
22. Lezon-Geyda K., Najfeld V., Johnson E.M. Deletions of PURA, at 5q31 and PURB, at 7p13, in myelodysplastic syndrome and progression to acute myelogenous leukemia. Leukemia. 15:2001;954-962
23. Dubourg C., Toutain B., Helias C., et al. Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene. Cancer Genet. Cytogenet. 134:2002;33-37
24. Xagorari A, Anagnou NP. Simplified and rapid approach for the selection of cDNAs encoded by YACs. Trends Genet 1997. http://www.tto.trends.com/T4002.
25. Kamakari S., Konstantinopoulou V., Anagnou N.P. First stage construction of a physical and transcriptional map of the 5q31 "critical region" associated with the 5q- syndrome. Eur. J. Hum. Genet. 6:1998;116
26. Kamakari S., Konstantinopoulou V., Anagnou N.P. Construction of a physical and transcript map of the 5q31 "critical region" associated with the 5q- syndrome. Blood. 92:1998;420a
27. Kamakari S, Konstantinopoulou V, Anagnou NP. Construction of a physical and transcript map of the 5q31 "critical region" associated with the 5q- syndrome. Eur J Hum Genet 1999;132.
28. Kamakari S., Konstantinopoulou V., Anagnou N.P. Physical and hematopoietic transcript map of a 5q31 "critical subregion" associated with the 5q- syndrome. Am. J. Hum. Genet. 67:2000;75
29. Konstantinopoulou V., Kamakari S., Ragoussis I., et al. Physical and hematopoietic transcript map of a 5q31 "critical subregion" associated with the 5q- syndrome. Leuk. Res. 25:2001;83
30. Heller A., Starke H., Trifonov V., et al. A complex translocation event between the two homologues of chromosomes 5 leading to a del (5)(q21q33) as a sole aberration in a case clinically diagnosed as CML: characterization of the aberration by multicolor banding. Int. J. Oncol. 20:2002;1179-1181
31. Hutchinson S., Furger A., Halliday D., et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum. Mol. Genet. 12:2003;2269-2276
32. Beaudoing E., Freier S., Wyatt J.R., et al. Patterns of variant polyadenylation signal usage in human genes. Genome Res. 10:2000;1001-1010
33. Mount S.M. Genomic sequence, splicing, and gene annotation. Am. J. Hum. Genet. 67:2000;788-792
34. Taki T., Kano H., Taniwaki M., et al. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23). Proc. Natl. Acad. Sci. U.S.A. 96:1999;14535-14540
35. McPherson P.S. Regulatory role of SH3 domain-mediated protein-protein interactions in synaptic vesicle endocytosis. Cell Signal. 11:1999;229-238
36. Ilsley J.L., Sudol M., Winder S.J. The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal. 14:2002;183-189
37. Hide W.A., Chan L., Li W.-H. Structure and evolution of the lipase superfamily. J. Lipid Res. 33:1992;167-178
38. Tani K., Mizoguchi T., Iwamatsu A., et al. p125 is a novel mammalian Sec23p-interacting protein with structural similarity to phospholipid-modifying proteins. J. Biol. Chem. 274:1999;20505-20512
39. Mizoguchi T., Nakajima K., Hatsuzawa K., et al. Determination of functional regions of p125, a novel mammalian Sec23p-interacting protein. Biochem. Biophys. Res. Commun. 279:2000;144-149
40. Sindelarova L., Zemanova Z., Brezinova S., et al. Multicolour banding fluorescence in situ hybridisation technique in the evaluation of 5q deletions. Leuk. Res. 27:2003;S29
41. Modrek B., Lee C. A genomic view of alternative splicing. Nat. Genet. 30:2002;13-19
42. Zhu Y., Jong M.C., Frazer K.A., et al. Genomic interval engineering of mice identifies a novel modulator of triglyceride production. Proc. Natl. Acad. Sci. U.S.A. 97:2000;11371142
43. Weber C.H., Park Y.S., Sanker S., et al. A prototypical cytidylyltransferase: CTP:glycerol-3-phosphate cytidylyltransferase from Bacillus subtilis. Struct. Fold Des. 7:1999;1113-1124
44. Freyberg Z., Siddhanta A., Shields D. 'Slip, sliding away': phospholipase D and the Golgi apparatus. Trends Cell Biol. 13:2003;540-546
45. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science. 287:2000;1606-1609
46. Capelluto D.G., Kutateladze T.G., Habas R., et al. The DIX domain targets dishevelled to actin stress fibres and vesicular membranes. Nature. 419:2002;726-729
47. Blumenthal T., Evans D., Link C.D., et al. A global analysis of Caenorhabditis elegans operons. Nature. 417:2002;851-854
48. Willert K., Brown J.D., Danenberg E., et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 423:2003;448-452
49. Pawson T., Scott J.D. Signaling through scaffold, anchoring, and adaptor proteins. Science. 278:1997;2075-2080
50. Kay B.K., Williamson M.P., Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J. 14:2000;231-241
51. Cadigan K.M., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 11:1997;3286-3305
52. Reya T., Duncan A.W., Ailles L., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature. 423:2003;409-414
53. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer, and cancer stem cells. Nature. 414:2001;105-111